-
Je něco špatně v tomto záznamu ?
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
N. Concin, X. Matias-Guiu, I. Vergote, D. Cibula, MR. Mirza, S. Marnitz, J. Ledermann, T. Bosse, C. Chargari, A. Fagotti, C. Fotopoulou, AG. Martin, S. Lax, D. Lorusso, C. Marth, P. Morice, RA. Nout, D. O'Donnell, D. Querleu, MR. Raspollini, J....
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- konsensus MeSH
- lidé MeSH
- nádory endometria * radioterapie MeSH
- radiační onkologie * MeSH
- rizikové faktory MeSH
- směrnice jako téma * MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.
Clinical Research Unit Institut Bergonie Bordeaux France
Department of Gynaecologic Oncology Imperial College London Faculty of Medicine UK
Department of Gynaecology Royal Marsden Hospital London UK
Department of Gynecology and Obstetrics Innsbruck Medical University Austria
Department of Gynecology and Obstetrics TU Dresden Medizinische Fakultat Carl Gustav Carus Germany
Department of Medical Oncology Amsterdam University Medical Centres Noord Holland Netherlands
Department of Medical Oncology Clinica Universidad de Navarra Madrid Spain
Department of Medical Oncology St James Hospital Dublin Ireland
Department of Obstetrics and Gynecologic Oncology University Hospital Strasbourg France
Department of Obstetrics and Gynecology Innsbruck Medical University Austria
Department of Oncology Rigshospitalet Copenhagen University Hospital Denmark
Department of Pathology Hospital Graz 2 Austria
Department of Pathology Hospital Universitari de Bellvitge University of Barcelona Idibell Spain
Department of Pathology Leids Universitair Medisch Centrum Leiden Netherlands
Department of Radiation Oncology Institut Gustave Roussy Villejuif France
Department of Radiation Oncology Leiden University Medical Center Leiden Netherlands
Department of Radiation Oncology Medical Faculty of the University of Cologne Germany
Department of Radiotherapy Erasmus MC Cancer Institute Rotterdam Netherlands
Department of Surgery Institut Gustave Roussy Villejuif France
Division of Gynecologic Oncology Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy
Evangelische Kliniken Essen Mitte Germany
Histopathology and Molecular Diagnostics Azienda Ospedaliero Universitaria Careggi Florence Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019594
- 003
- CZ-PrNML
- 005
- 20210830101159.0
- 007
- ta
- 008
- 210728s2021 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.radonc.2020.11.018 $2 doi
- 035 __
- $a (PubMed)33712263
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Concin, Nicole $u Department of Gynecology and Obstetrics, Innsbruck Medical University, Austria; Evangelische Kliniken Essen-Mitte, Germany. Electronic address: nicole.concin@i-med.ac.at
- 245 10
- $a ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma / $c N. Concin, X. Matias-Guiu, I. Vergote, D. Cibula, MR. Mirza, S. Marnitz, J. Ledermann, T. Bosse, C. Chargari, A. Fagotti, C. Fotopoulou, AG. Martin, S. Lax, D. Lorusso, C. Marth, P. Morice, RA. Nout, D. O'Donnell, D. Querleu, MR. Raspollini, J. Sehouli, A. Sturdza, A. Taylor, A. Westermann, P. Wimberger, N. Colombo, F. Planchamp, CL. Creutzberg
- 520 9_
- $a A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.
- 650 _2
- $a konsensus $7 D032921
- 650 12
- $a nádory endometria $x radioterapie $7 D016889
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a směrnice jako téma $7 D017408
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a radiační onkologie $7 D018787
- 650 _2
- $a rizikové faktory $7 D012307
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Matias-Guiu, Xavier $u Department of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain; Department of Pathology, Hospital Universitari de Bellvitge, University of Barcelona, Idibell, Spain
- 700 1_
- $a Vergote, Ignace $u Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Belgium
- 700 1_
- $a Cibula, David $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic
- 700 1_
- $a Mirza, Mansoor Raza $u Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark
- 700 1_
- $a Marnitz, Simone $u Department of Radiation Oncology, Medical Faculty of the University of Cologne, Germany
- 700 1_
- $a Ledermann, Jonathan $u UCL Cancer Institute, University College, London, UK
- 700 1_
- $a Bosse, Tjalling $u Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Netherlands
- 700 1_
- $a Chargari, Cyrus $u Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
- 700 1_
- $a Fagotti, Anna $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
- 700 1_
- $a Fotopoulou, Christina $u Department of Gynaecologic Oncology, Imperial College London Faculty of Medicine, UK
- 700 1_
- $a Martin, Antonio Gonzalez $u Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain
- 700 1_
- $a Lax, Sigurd $u Department of Pathology, Hospital Graz II, Austria; School of Medicine, Johannes Kepler University Linz, Austria
- 700 1_
- $a Lorusso, Domenica $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
- 700 1_
- $a Marth, Christian $u Department of Obstetrics and Gynecology, Innsbruck Medical University, Austria
- 700 1_
- $a Morice, Philippe $u Department of Surgery, Institut Gustave Roussy, Villejuif, France
- 700 1_
- $a Nout, Remi A $u Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, Netherlands
- 700 1_
- $a O'Donnell, Dearbhaile $u Department of Medical Oncology, St James Hospital, Dublin, Ireland
- 700 1_
- $a Querleu, Denis $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Department of Obstetrics and Gynecologic Oncology, University Hospital, Strasbourg, France
- 700 1_
- $a Raspollini, Maria Rosaria $u Histopathology and Molecular Diagnostics, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
- 700 1_
- $a Sehouli, Jalid $u Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Germany
- 700 1_
- $a Sturdza, Alina $u Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria
- 700 1_
- $a Taylor, Alexandra $u Department of Gynaecology, Royal Marsden Hospital, London, UK
- 700 1_
- $a Westermann, Anneke $u Department of Medical Oncology, Amsterdam University Medical Centres, Noord-Holland, Netherlands
- 700 1_
- $a Wimberger, Pauline $u Department of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Germany
- 700 1_
- $a Colombo, Nicoletta $u Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan and University of Milan-Bicocca, Italy
- 700 1_
- $a Planchamp, François $u Clinical Research Unit, Institut Bergonie, Bordeaux, France
- 700 1_
- $a Creutzberg, Carien L $u Department of Radiation Oncology, Leiden University Medical Center, Leiden Netherlands
- 773 0_
- $w MED00004049 $t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 154, č. - (2021), s. 327-353
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33712263 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101159 $b ABA008
- 999 __
- $a ok $b bmc $g 1690425 $s 1140040
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 154 $c - $d 327-353 $e - $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
- LZP __
- $a Pubmed-20210728
